GB Patent

GB0602767D0 — Treatment of muscular dystrophy

Assigned to Summit Therapeutics Ltd · Expires 2006-03-22 · 20y expired

What this patent protects

Patent listed against Exondys 51.

Drugs covered by this patent

Exondys 51 (ETEPLIRSEN) · Sarepta

Patent Metadata

Patent number: GB0602767D0
Jurisdiction: GB
Classification: —
Expires: 2006-03-22
Drug substance claim: No
Drug product claim: No
Assignee: Summit Therapeutics Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.